ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
FFP transfusion did not reduce 30-day mortality in pts undergoing cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study
Friday, October 11, 2013
Submitted by
Source
Source Name: Transfusion
This cohort study looks at the Administration of FFP in bleeding patients after cardiac surgery. it finds no difference in mortality in the FFP group and the no FFP group
Printer-friendly
